Results 101 to 110 of about 4,816,902 (277)
2025: A Bright Year Ahead for Future Pharmacology
As 2024 is coming to an end, let us reflect on Future Pharmacology’s achievements to better understand what is promising to be a bright year ahead [...]
Fabrizio Schifano
doaj +1 more source
Detecting novel psychoactive substances around the world
Purpose of review The worldwide spread of novel psychoactive substances (NPS) in the illicit drug market and their continuous increase in number and type, for the purpose of bypassing controlled substance legislation, represents a continuing challenge for forensic scientists, clinicians and enforcement authorities.
Salomone, Alberto, Vincenti, Marco
openaire +3 more sources
Enhancing quality of mental health service for veterans with seizures
Abstract Psychiatric disorders are commonly identified in people with seizures (PWS). Comorbid mood, anxiety, and trauma‐ and stressor‐related disorders are highly prevalent and not consistently recognized or treated promptly. Veterans with seizures are particularly vulnerable to neuropsychiatric comorbidities, including a higher prevalence of ...
Maria Raquel Lopez +6 more
wiley +1 more source
2023: The Best Year Ever for Future Pharmacology (and Even Better Years to Come)
The end of any year provides an opportunity to reflect on the past, and in particular, the past twelve months [...]
Fabrizio Schifano
doaj +1 more source
Abstract Objective Levetiracetam (LEV) is an antiseizure medication approved for focal and generalized epilepsy. Despite its efficacy, neuropsychiatric adverse effects (NP‐AEs) may lead to treatment discontinuation. Quantitative electroencephalographic (qEEG) graph‐theoretical analysis has emerged as a valuable tool for identifying neurophysiological ...
Marco Sferruzzi +10 more
wiley +1 more source
Abstract Drug‐resistant epilepsy (DRE) affects approximately one‐third of patients with epilepsy and represents a major unmet clinical need. While traditional hypotheses of pharmacoresistance have focused on alterations in drug targets, efflux transporter overexpression, and intrinsic disease severity, the gut microbiome has recently emerged as a ...
Khaled Zammar +4 more
wiley +1 more source
COVID-19: The Hidden Impact on Mental Health and Drug Addiction
Stefania Chiappini +5 more
doaj +1 more source
Background: “Chemsex” involves the intake of a range of drugs (e.g., synthetic cathinones, gamma-hydroxybutyric acid/gamma-butyrolactone (GHB/GBL), ketamine, methamphetamine, “poppers”, type V phosphodiesterase (PDE) inhibitors, MDMA/ecstasy, cocaine ...
Fabrizio Schifano +8 more
doaj +1 more source
Sleep Health in Bulimia Nervosa: A Systematic Review
ABSTRACT Objective Research on sleep in bulimia nervosa (BN) is methodologically varied and yields inconsistent findings. This review synthesised BN‐sleep studies and examined whether comorbid mood disorders contribute to sleep disturbance. Method PsycINFO, Medline (Ovid), and Scopus were searched for English or French quantitative studies comparing ...
Samantha Kenny +4 more
wiley +1 more source
Background/Objectives: The misuse of veterinary drugs is a growing concern, with increasing evidence of their presence in illicit drug markets and their use as alternatives to traditional substances. Methods: This study explores Reddit discussions on the
Josie Dunn +4 more
doaj +1 more source

